Vagus nerve stimulation for reducing postoperative atrial fibrillatio
- Conditions
- Postoperative atrial fibrillation.Paroxysmal atrial fibrillationI48.0
- Registration Number
- IRCT20130707013886N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Adult subjects who are candidate for an elective CABG
Age = 18
Sinus rhythm at baseline ECG
Patients with a documented history of AF and other supraventricular arrhythmia
Hemodynamic instability that required inotropic agents
Severe congestive heart failure (New York Heart Association class III or IV)
Congenital heart disease
Chronic use of amiodarone
High-degree atrioventricular block that required temporary pacing
Symptomatic sinus bradycardia or sinus node dysfunction at baseline without an implantable pacemaker
Recent stroke within the past 6 months
Recurrent vasovagal syncope
Known channelopathy such as Brugada syndrome, long QT syndrome, or Catecholaminergic monomorphic ventricular tachycardia
The presence of a pacemaker or an implanted cardioverter-defibrillator
Pregnancy
Facial or ear pain, or recent ear trauma
Unable or unwilling to comply with protocol requirements
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility of the intervention. Timepoint: At the end of the study. Method of measurement: The amount of time (in minutes) of device use per day and Number of completed session.;Feasibility of the measurements and assessments procedures. Timepoint: At the end of the study. Method of measurement: The number of completed assessments.;Acceptability of the intervention. Timepoint: At the end of the study. Method of measurement: TAQ questionnaire.;Safety of the study. Timepoint: After intervention on a daily basis. Method of measurement: Physical examination.
- Secondary Outcome Measures
Name Time Method